RAS-modification as a novel therapy for pulmonary indications in T2D

负责人：

关键词：

Clinical and Experimental Therapeutics T2DM angiotensin(1-7) immune function lung fibrosis pulmonary indications

DOI：

doi:10.25549/usctheses-c40-350071

摘要：

y harvest future therapies for patients with potential chronic pulmonary conditions. Overall, RAS-modification may be a viable therapeutic target to treat

Data from: Characterization of regional left ventricular function in nonhuman primates using magnetic resonance imaging biomarkers: a test-retest

负责人：

关键词：

magnetic resonance imaging cardiac function cardiac tagging phase contrast MRI non-human primates cynomolgus

DOI：

doi:10.5061/dryad.6tm5v

摘要：

phenotyping, prediction of downstream remodeling, and evaluation of novel experimental therapeutics. This paper sheds insight into NHP cardiac function throug

Therapeutic potential of rhesus theta (θ) defensin-1 in cystic fibrosis airway infection and inflammation

负责人：

关键词：

Clinical and Experimental Therapeutics cystic fibrosis infection inflammation preclinical drug development

DOI：

doi:10.25549/usctheses-c40-309144

摘要：

to bronchiectasis and progressive loss of lung function. Despite improvements with aggressive antibiotics and airway clearance therapies, the life expecta